Roche deal is super and only the beginning of deals
Wow I read the details of the Roche deal and it is super. Big funding for PRECLINICAL studies. In other words, they will pay the entire tab for Phase I, II, and III...[Roche will make a $10 million up-front payment to Inovio with development and commercial milestones of up to $412.5 million] Goodbye dilution worries. Best of all they only made a deal on two product lines, plenty more to do. I can see Gates funding malaria, Merck, Novartis competing. Roche is BIG TIME, they bought Genetech I believe, so to have their validation of the technology is awesome. They know biotech value. Shorts have been carping that preclinicals were worthless. Today we saw just how valuable they really are.